Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-020006
Filing Date
2023-03-14
Accepted
2023-03-14 17:22:05
Documents
81
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_longeveron.htm   iXBRL 10-K 1506901
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2022ex23-1_longeveron.htm EX-23.1 1908
3 CONSENT OF FORMER INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2022ex23-2_longeveron.htm EX-23.2 2227
4 CERTIFICATION f10k2022ex31-1_longeveron.htm EX-31.1 8996
5 CERTIFICATION f10k2022ex31-2_longeveron.htm EX-31.2 8869
6 CERTIFICATION f10k2022ex32-1_longeveron.htm EX-32.1 3431
7 CERTIFICATION f10k2022ex32-2_longeveron.htm EX-32.2 3317
13 GRAPHIC image_001.jpg GRAPHIC 49481
  Complete submission text file 0001213900-23-020006.txt   6674012

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE lgvn-20221231.xsd EX-101.SCH 75682
9 XBRL CALCULATION FILE lgvn-20221231_cal.xml EX-101.CAL 36720
10 XBRL DEFINITION FILE lgvn-20221231_def.xml EX-101.DEF 313180
11 XBRL LABEL FILE lgvn-20221231_lab.xml EX-101.LAB 601073
12 XBRL PRESENTATION FILE lgvn-20221231_pre.xml EX-101.PRE 331415
75 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_longeveron_htm.xml XML 615493
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40060 | Film No.: 23732078
SIC: 2834 Pharmaceutical Preparations